Benzinga | Nov 1, 2021 06:46AM EDT

ANI Pharmaceuticals Q3 EPS $1.01 Beats $0.70 Estimate, Sales $52.10M Beat $49.70M Estimate

ANI Pharmaceuticals (NASDAQ:ANIP) reported quarterly earnings of $1.01 per share which beat the analyst consensus estimate of $0.70 by 44.29 percent. This is a 4.12 percent increase over earnings of $0.97 per share from the same period last year. The company reported quarterly sales of $52.10 million which beat the analyst consensus estimate of $49.70 million by 4.83 percent. This is a 1.66 percent decrease over sales of $52.98 million the same period last year.